Mustang Bio Balance Sheet Health
Financial Health criteria checks 5/6
Mustang Bio has a total shareholder equity of $29.8M and total debt of $27.6M, which brings its debt-to-equity ratio to 92.5%. Its total assets and total liabilities are $73.6M and $43.8M respectively.
Key information
92.5%
Debt to equity ratio
US$27.58m
Debt
| Interest coverage ratio | n/a |
| Cash | US$58.10m |
| Equity | US$29.82m |
| Total liabilities | US$43.79m |
| Total assets | US$73.61m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2W60's short term assets ($61.1M) exceed its short term liabilities ($12.7M).
Long Term Liabilities: 2W60's short term assets ($61.1M) exceed its long term liabilities ($31.1M).
Debt to Equity History and Analysis
Debt Level: 2W60 has more cash than its total debt.
Reducing Debt: 2W60's debt to equity ratio has increased from 0% to 92.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2W60 has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 2W60 is forecast to have sufficient cash runway for 12 months based on free cash flow estimates, but has since raised additional capital.